Research progress on pathogenesis of skin graft-versus-host disease
10.3969/j.issn.1674-7445.2022.01.018
- VernacularTitle:皮肤移植物抗宿主病发病机制研究进展
- Author:
Xiaoyan LI
1
;
Rui XI
;
Hai BAI
Author Information
1. The First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou 730000, China
- Publication Type:Research Article
- Keywords:
Hematopoietic stem cell transplantation;
Graft-versus-host disease;
Interleukin-22;
Interleukin-17;
Interleukin-6;
Interferon-γ;
Signal transducer and activator of transcription (STAT);
Baricitinib;
Ruxolitinib
- From:
Organ Transplantation
2022;13(1):120-
- CountryChina
- Language:Chinese
-
Abstract:
Graft-versus-host disease (GVHD) is a major cause that prevents widespread application of allogeneic hematopoietic stem cell transplantation. GVHD is a complication that can affect all systems of the body, such as skin, liver, lung and gastrointestinal tract, among which skin is the most vulnerable organ. At present, the pathogenesis of skin GVHD has not been fully elucidated, and no effective treatment has been established. Severe or extensive chronic GVHD significantly affects the quality of life of the recipients. Consequently, it is urgent to unravel the pathogenesis of skin GVHD and explore novel therapeutic treatment. Cytokines, such as interleukin (IL)-22, IL-17, IL-6 and interferon (IFN)-γ, have been proven to play pivotal roles in the progression of skin GVHD. Nevertheless, the specific mechanism remains elusive. In this article, research progresses at home and abroad on the mechanism underlying the roles of these cytokines in skin GVHD were reviewed, aiming to provide novel ideas for the prevention and treatment of skin GVHD.
